ICOS is essential for the development of experimental autoimmune myasthenia gravis

Journal of Neuroimmunology

Volumn 153, Issue 1-2, 2004, Pages 16-25

  Scott, Benjamin G ^a   Yang, Huan ^a   Tüzün, Erdem ^a   Dong, Chen ^b   Flavell, Richard A ^c   Christadoss, Premkumar ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bungarotoxin; Ab; acetylcholine receptor; AChR; antibody; antigen presenting cell; APC; Autoimmunity; B7RP 1; BTX; Costimulation; EAMG; Experimental autoimmune myasthenia gravis; experimental autoimmune myasthenia gravis; ICOS; Ig; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR; INDUCIBLE COSTIMULATORY MOLECULE; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOID TISSUE; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL COUNT; CELL DIVISION; COMPLEMENT C3; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GERMINAL CENTER; IMMUNIZATION; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYASTHENIA GRAVIS, AUTOIMMUNE, EXPERIMENTAL; NEUROMUSCULAR JUNCTION; PEPTIDES; RADIOIMMUNOASSAY; RECEPTORS, CHOLINERGIC; T-LYMPHOCYTES; TIME FACTORS; TORPEDO;

EID: 3242721247     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.04.019     Document Type: Article

References (34)

1. Aicher A., Hayden-Ledbetter M., Brady W.A., Pezzutto A., Richter G., Magaletti D., Buckwalter S., Ledbetter J.A., Clark E.A. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164:2000;4689-4896
2. Christadoss P., Dauphinee M.J. Immunotherapy for myasthenia gravis: a murine model. J. Immunol. 136:1986;2437-2440
3. Christadoss P., Poussin M., Deng C. Animal Models of Myasthenia Gravis. Clin. Immunol. 94:2000;75-87
4. Coyle A.J., Lehar S., Lloyd C., Tian J., Delaney T., Manning S., Nguyen T., Burwell T., Schneider H., Gonzalo J.A., Gosselin M., Owen L.R., Rudd C.E., Gutierrez-Ramos J.C. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity. 13:2000;95
5. Dong C., Juedes A.E., Temann U.A., Shresta S., Allison J.P., Ruddle N.H., Flavell R.A. ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature. 409:2001;97-101
6. Dong C., Temann U.A., Flavell R.A. Cutting edge: critical role of inducible costimulator in germinal center reactions. J. Immunol. 166:2001;3659-3662
7. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330:1994;1797-1810
8. Engel A.G., Lambert A.H., Howard F.M. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin. Proc. 52:1977;267-280
9. Hutloff A., Dittrich A.M., Beier K.C., Eljaschewitsch B., Kraft R., Anagnostopoulos I., Kroczek R.A. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature. 397:1999;263-266
10. Iwai H., Kozono Y., Hirose S., Akiba H., Yagita H., Okumura K., Kohsaka H., Miyasaka N., Azuma M. Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation. J. Immunol. 169:2002;4332-4339
11. Kaul R., Shenoy M., Christadoss P. The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis. Adv. Neuroimmunol. 4:1994;387-402
12. Kaul R., Shenoy M., Goluszko E., Christadoss P. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. J. Immunol. 152:1994;3152-3157
13. Kopf M., Coyle A.J., Schmitz N., Barner M., Oxenius A., Gallimore A., Gutierrez-Ramos J.C., Bachmann M.F. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192:2000;53-61
14. Lindstrom J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74:1981;432-460
15. + T cells. J. Immunol. 165:2000;5035-5040
16. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., Freeman G.J., Sharpe A.H. ICOS is critical for CD40-mediated antibody class switching. Nature. 409:2001;102-105
17. Nurieva R.I., Treuting P., Duong J., Flavell R.A., Dong C. Inducible costimulator is essential for collagen-induced arthritis. J. Clin. Invest. 111:2003;701-706
18. Ogasawara K., Yoshinaga S.K., Lanier L.L. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells. J. Immunol. 169:2002;3676-3685
19. Ozkaynak E., Gao W., Shemmeri W.N., Wang C., Gutierrez-Ramos J.C., Amaral J., Qin J.S., Rottman J.B., Coyle A.J., Hancock W.W. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol. 2:2001;591-596
20. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 180:1973;871-872
21. Poussin M.A., Tuzun E., Goluszko E., Scott B.G., Yang H., Franco J.U., Christadoss P. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis. J. Immunol. 170:2003;4389-4396
22. Rottman J.B., Smith T., Tonra J.R., Ganley K., Bloom T., Silva R., Pierce B., Gutierrez-Ramos J.C., Ozkaynak E., Coyle A.J. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2:2001;605-611
23. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19:2001;225-252
24. Shi F.D., He B., Li H., Matusevicius D., Link H., Ljunggren H.G. Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. Eur. J. Immunol. 28:1998;3587-3593
25. Sperling A.I. ICOS costimulation: is it the key to selective immunotherapy? Clin. Immunol. 100:2001;261-262
26. Sperling A.I., Bluestone J.A. ICOS costimulation: it's not just for Th2 cells anymore. Nat. Immunol. 2:2001;573-574
27. Sporici R.A., Beswick R.L., von Allmen C., Rumbley C.A., Hayden-Ledbetter M., Ledbetter J.A., Perrin P.J. ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin. Immunol. 100:2001;277-288
28. Swallow M.M., Wallin J.J., Sha W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF alpha. Immunity. 11:1999;423-432
29. Tafuri A., Shahinian A., Bladt F.S., Yoshinaga K., Jordana M., Wakeham A., Boucher L.M., Bouchard D., Chan V.S., Duncan G., Odermatt B., Ho A., Itie A., Horan T., Whoriskey J.S., Pawson T., Penninger J.M., Ohashi P.S., Mak T.W. ICOS is essential for effective T-helper-cell responses. Nature. 409:2001;105-109
30. Tsujihata M., Yoshimura T., Satoh A., Kinoshita I., Matsuo H., Mori M., Nagataki S. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis. Neurology. 39:1989;1359-1363
31. Tuzun E., Scott B.G., Goluszko E., Higgs S., Christadoss P. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis. J. Immunol. 171:2003;3847-3854
32. Wu B., Goluszko E., Christadoss P. Experimental autoimmune myasthenia gravis in the mouse. Coligan J., Shevach E., Strober W. Current Protocols of Immunology. vol. 3:15:1997;8.1 Wiley, New York
33. Yoshinaga S.K., Whoriskey J.S., Khare S.D., Sarmiento U., Guo J., Horan T., Shih G., Zhang M., Coccia M.A., Kohno T., Tafuri-Bladt A., Brankow D., Campbell P., Chang D., Chiu L., Dai T., Duncan G., Elliott G.S., Hui A., McCabe S.M., Scully S., Shahinian A., Shaklee C.L., Van G., Mak T.W., et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature. 402:1999;827-832
34. + T cells are essential to induce experimental autoimmune myasthenia gravis. J. Exp. Med. 184:1996;349-356